it is concluded that nahco3 therapy in diabetic ketoacidosis decreases the cerebral o2 availability and that cerebral hypoxia contributes to the brain dysfunction encountered after the initiation of such therapy in acidemia .
C0030054
o2
C1527348
cerebral